Article Test

The treatment of pediatric oncology patients involves the use of specialized drugs adapted to their specific needs, thus, in view of the need for pharmacotherapeutic follow-up with oral dosage forms (ODF), in the unavailability of liquid formulations, a strategy is the preparation of extemporaneous solutions from the manipulation of tablets and capsules added to liquid vehicles (eg: water, simple syrup) adjusting palatability and facilitating access. This review article will serve as a guide, providing information on the preparation, stability and storage of extemporaneous oral chemotherapy formulations (tablets, capsules, injection powder or injection solution) for use in clinical practice, with the aim of promoting adherence to treatment linked to safety and effectiveness, based on good handling practices and occupational risk. The results of this review are summarized in a table and based on a composition of the cited documents, tests carried out and the authors' judgment on all the data collected. Twenty drugs were identified as potentially important for clinical practice. Strategies for preparing extemporaneous solutions of chemotherapeutic agents for pediatric patients require more scientific data or even publications of adaptations used. Even with the scarcity of data for some drugs, this review covers the most trivial drugs in clinical practice, including information on preparation, warning about stability and storage, and also included relevant guidelines on the mode of administration in view of the adherence and effectiveness of the drug. The professional who handles these cytotoxic drugs needs to understand from pharmacotechnical aspects and guard against exposure in the preparation, so that he can continue to guarantee access and adherence to treatment and follow rigorous literature and protocols, implementing the best practices and providing adequate, effective, and personalized treatment.